CHESAPEAKE GENOMIC SYSTEMS LLC
Synthetic circular supercoiled DNA: an alternative to plasmids for the production of lentiviral vectors for cell and gene therapies
Synthetic circular supercoiled DNA: an alternative to plasmids for the production of lentiviral vectors for cell and gene therapies is a funding opportunity from CHESAPEAKE GENOMIC SYSTEMS LLC, up to 306872, closing August 31, 2026.
Aug 31, 2026
(31d left)Overview
PROJECT SUMMARY/ ABSTRACT Bacterial plasmid manufacture is now a major bottleneck in viral gene therapy production workflows. Although supercoiled plasmid-based vectors are the current industry standard for transient transfection of packaging cells, minimized DNAs offer substantial safety and efficiency advantages.…